MIRD continuing education: Bystander and low-dose-rate effects: Are these relevant to radionuclide therapy?

Journal of Nuclear Medicine

Volumn 48, Issue 10, 2007, Pages 1683-1691

  Sgouros, George ^a,f   Knox, Susan J ^b   Joiner, Michael C ^c   Morgan, William F ^d   Kassis, Amin I ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f CRB   (United States)

Author keywords

Bystander effects; Dosimetry; Low dose rate effects; Radiation safety; Radiobiology; Radionuclide therapy

Indexed keywords

BYSTANDER EFFECT; CANCER RADIOTHERAPY; CELL SURVIVAL; CONTINUING EDUCATION; DOSE RESPONSE; DOSIMETRY; HUMAN; IONIZING RADIATION; LIVER CELL CARCINOMA; LUNG CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIATION SAFETY; REVIEW; SCINTISCANNING;

ANIMALS; BYSTANDER EFFECT; CELL PHYSIOLOGY; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RADIATION DOSAGE;

EID: 35348880383     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.105.028183     Document Type: Review

References (112)

1. Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from a-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA. 2001;98:473-478.
2. Sowd Resat MB, Morgan WF. Radiation-induced genomic instability: a role for secreted soluble factors in communicating the radiation response to non-irradiated cells. J Cell Biochem. 2004;92:1013-1019.
3. Iyer R, Lehnert BE. Factors underlying the cell growth-related bystander responses to a particles. Cancer Res. 2000;60:1290-1298.
4. Narayanan PK, Goodwin EH, Lehnert BE. α particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res. 1997;57:3963-3971.
5. Narayanan PK, LaRue KEA, Goodwin EH, Lehnert BE. Alpha particles induce the production of interleukin-8 by human cells. Radiat Res. 1999;152:57-63.
6. Shao C, Stewart V, Folkard M, Michael BD, Prise KM. Nitric oxide-mediated signaling in the bystander response of individually targeted glioma cells. Cancer Res. 2003;63:8437-8442.
7. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res. 2003;159:567-580.
8. Morgan WF. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res. 2003;159:581-596.
9. Morgan WF, Sowa MB. Non-targeted bystander effects induced by ionizing radiation. Mutat Res. 2007;616:159-164.
10. Wright EG, Coates PJ. Untargeted effects of ionizing radiation: implications for radiation pathology. Mutat Res. 2006;597:119-132.
11. Sokolov MV, Smilenov LB, Hall EJ, Panyutin IG, Bonner WM, Sedelnikova OA. Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts. Oncogene. 2005;24:7257-7265.
12. Iyer R, Lehnert BE. Low dose, low-LET ionizing radiation-induced radio-adaptation and associated early responses in unirradiated cells. Mutat Res. 2002;503:1-9.
13. Hall EJ. The bystander effect. Health Phys. 2003;85:31-35.
14. Parsons WB Jr, Watkins CH, Pease GL, Childs DS Jr. Changes in sternal marrow following roentgen-ray therapy to the spleen in chronic granulocytic leukemia. Cancer. 1954;7:179-189.
15. Mothersill C, Seymour C. Radiation-induced bystander effects: past history and future directions. Radiat Res. 2001;155:759-767.
16. Nagasawa H, Little JB. Induction of sister chromatid exchanges by extremely low doses of a-particles. Cancer Res. 1992;52:6394-6396.
17. Zhou H, Randers-Pehrson G, Waldren CA, Vannais D, Hall EJ, Hei TK. Induction of a bystander mutagenic effect of alpha particles in mammalian cells. Proc Natl Acad Sci USA. 2000;97:2099-2104.
18. Sawant SG, Zheng W, Hopkins KM, Randers-Pehrson G, Lieberman HB, Hall EJ. The radiation-induced bystander effect for clonogenic survival. Radiat Res. 2002;157:361-364.
19. Persaud R, Zhou H, Baker SE, Hei TK, Hall EJ. Assessment of low linear energy transfer radiation-induced bystander mutagenesis in a three-dimensional culture model. Cancer Res. 2005;65:9876-9882.
20. Bishayee A, Hill HZ, Stein D, Rao DV, Howell RW. Free radical-initiated and gap junction-mediated bystander effect due to nonuniform distribution of incorporated radioactivity in a three-dimensional tissue culture model. Radiat Res. 2001;155:335-344.
21. Bishayee A, Rao DV, Howell RW. Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. Radiat Res. 1999;152:88-97.
22. Xue LY, Butler NJ, Makrigiorgos GM, Adelstein SJ, Kassis AI. Bystander effect produced by radiolabeled tumor cells in vivo. Proc Natl Acad Sci USA. 2002;99:13765-13770.
23. Mole RH. Whole body irradiation: radiobiology or medicine. Br J Radiol. 1953;26:234-241.
24. Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J. The controversial abscopal effect. Cancer Treat Rev. 2005;31:159-172.
25. Ohba K, Omagari K, Nakamura T, et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut. 1998;43:575-577.
26. Camphausen K, Moses MA, Menard C, et al. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 2003;63:1990-1993.
27. Jansen CR, Bond VP, Rai KR, Lippincott SW. Abscopal effects of localized irradiation by accelerator beams. Ann N Y Acad Sci. 1964;114:302-315.
28. Konoeda K. Therapeutic efficacy of pre-operative radiotherapy on breast carcinoma: in special reference to its abscopal effect on metastatic lymphnodes [in Japanese]. Nippon Gan Chiryo Gakkai Shi. 1990;25:1204-1214.
29. Nobler MP. Abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology. 1969;93:410-412.
30. Petrovic N, Perovic J, Karanovic D, Todorovic L, Petrovic V. Abscopal effects of local fractionated x-irradiation of face and jaw region. Strahlentherapie. 1982;158:40-42.
31. Raventos A. An abscopal effect of X-ray upon mouse spleen weight. Radiat Res. 1954;1:381-387.
32. Rees GJ, Ross CM. Abscopal regression following radiotherapy for adenocarcinoma. Br J Radiol. 1983;56:63-66.
33. Szeifert GT, Salmon I, Rorive S, et al. Does gamma knife surgery stimulate cellular immune response to metastatic brain tumors? A histopathological and immunohistochemical study. J Neurosurg. 2005;102:180-184.
34. Van der Meeren A, Monti P, Vandamme M, Squiban C, Wysocki J, Griffiths N. Abdominal radiation exposure elicits inflammatory responses and abscopal effects in the lungs of mice. Radiat Res. 2005;163:144-152.
35. Wersall PJ, Blomgren H, Pisa P, Lax I, Kalkner KM, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol. 2006;45:493-497.
36. Law AW, Mole RH. Direct and abscopal effects of x-radiation on the thymus of the weanling rat. Int J Radiat Biol. 1961;3:233-248.
37. 125I. Micron. 2002;33:127-132.
38. Boyd M, Ross SC, Dorrens J, et al. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β, and Auger electron-emitting radionuclides. J Nucl Med. 2006;47:1007-1015.
39. Kishikawa H, Wang K, Adelstein SJ, Kassis AI. Inhibitory and stimulatory bystander effects are differentially induced by iodine-125 and iodine-123. Radiat Res. 2006;165:688-694.
40. Kassis AI, Adelstein SJ. Radiobiologic principles in radionuclide therapy. J Nucl Med. 2005;46(suppl):4S-12S.
41. Kassis AI. The amazing world of Auger electrons. Int J Radiat Biol. 2004;80:789-803.
42. Little JB. Genomic instability and bystander effects: a historical perspective. Oncogene. 2003;22:6978-6987.
43. Morgan WF. Is there a common mechanism underlying genomic instability, bystander effects and other nontargeted effects of exposure to ionizing radiation? Oncogene. 2003;22:7094-7099.
44. Lorimore SA, Coates PJ, Wright EG. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene. 2003;22:7058-7069.
45. Gridley DS, Williams JR, Slater JM. Low-dose/low-dose rate radiation: a feasible strategy to improve cancer radiotherapy? Cancer Ther. 2005;3:105-130.
46. 60Co gamma rays on human tumor cells in vitro. Radiat Res. 2002;158:311-318.
47. Mitchell CR, Joiner MC. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures. Int J Radiat Biol. 2002;78:981-990.
48. Knox SJ, Goris ML, Wessels BW. Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation. Radiother Oncol. 1992;23:111-117.
49. Knox SJ. Overview of studies on experimental radioimmunotherapy. Cancer Res. 1995;55(suppl):S5832-S5836.
50. Knox SJ, Levy R, Miller RA, et al. Determinants of the antitumor effect of radiolabeled monoclonal antibodies. Cancer Res. 1990;50:4935-4940.
51. Travis EL, Peters LJ, McNeill J, Thames HD, Karolis C. Effect of dose-rate on total-body irradiation: lethality and pathologic findings. Radiother Oncol. 1985;4:341-351.
52. Knox SJ, Goris ML, Tempero M, et al. Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clin Cancer Res. 2000;6:406-414.
53. Press OW, Eary JF, Appelbaum FR, et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone-marrow support. N Engl J Med. 1993;329:1219-1224.
54. Vilenchik MM, Knudson AG. Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage rates. Proc Natl Acad Sci USA. 2000;97:5381-5386.
55. Shen RN, Hornback NB, Lu L, Chen LT, Brahmi Z, Broxmeyer HE. Low-dose total-body irradiation: a potent anti-retroviral agent in vivo. Int J Radiat Oncol Biol Phys. 1989;16:165-170.
56. Wolff S, Wienecke JK, Afzal V, Youngblom J, Cortes F. The adaptive response of human lymphocytes to very low dose ionizing radiation: a case of induced chromosomal repair with the induction of specific proteins. In: Braverstock KF, Stather JW, eds. Low Dose Radiation: Biological Basis of Risk Assessment. London, U.K.: Taylor and Francis; 1989:446-454.
57. Fujiki H, Suganuma M. Tumor-necrosis-factor-alpha, a new tumor promoter, engendered by biochemical-studies of okadaic acid. J Biochem (Tokyo). 1994;115:1-5.
58. Bhattacharjee D. Role of radioadaptation on radiation-induced thymic lymphoma in mice. Mutat Res. 1996;358:231-235.
59. Mitchel REJ, Jackson JS, McCann RA, Boreham DR. The adaptive response modifies latency for radiation-induced myeloid leukemia in CBA/H mice. Radiat Res. 1999;152:273-279.
60. Bhattacharjee D, Sarma HR. Suppression of tumor growth in mice by low dose gamma radiation. In: Goel SC, ed. Advances in Radiation Biology and Peace. Muzaffarnagar, India: The U.P. Zoological Society; 1999:187-192.
61. Cheda A, Wrembel-Wargocka J, Lisiak E, Nowosielska EM, Marciniak M, Janiak MK. Single low doses of X rays inhibit the development of experimental tumor metastases and trigger the activities of NK cells in mice. Radiat Res. 2004;161:335-340.
62. Cai L. Research of the adaptive response induced by low-dose radiation: where have we been and where should we go? Hum Exp Toxicol. 1999;18:419-425.
63. Hashimoto S, Shirato H, Hosokawa M, et al. The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats. Radiat Res. 1999;151:717-724.
64. Anderson RE, Tokuda S, Williams WL, Warner NL. Radiation-induced augmentation of the response of A/J mice to SaI tumor-cells. Am J Pathol. 1982;108:24-38.
65. Duhrsen U, Metcalf D. A model system for leukemic transformation of immortalized hematopoietic-cells in irradiated recipient mice. Leukemia. 1988;2:329-333.
66. Gridley DS, Andres ML, Slater JM. Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor. Anticancer Res. 1997;17:923-928.
67. Williams JA, Williams JR, Yuan X, Dillehay LE. Protracted exposure radio-sensitization of experimental human malignant glioma. Radiat Oncol Investig. 1998;6:255-263.
68. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys. 2001;49:379-389.
69. Shipley WU, Peacock JH, Steel GG, Stephens TC. Continuous irradiation of the Lewis lung-carcinoma in vivo at clinically-used ultra low-dose-rates. Int J Radiat Oncol Biol Phys. 1983;9:1647-1653.
70. Marples B, Wouters BG, Joiner MC. An association between the radiation-induced arrest of G(2)-phase cells and low-dose hyper- radiosensitivity: a plausible underlying mechanism? Radiat Res. 2003;160:38-45.
71. Deweese TL, Shipman JM, Dillehay LE, Nelson WG. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. J Urol. 1998;159:591-598.
72. 2-phase cells. Radiat Res. 2004;161:247-255.
73. Collis SJ, Schwaninger JM, Ntambi AJ, et al. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J Biol Chem. 2004;279:49624-49632.
74. Chalmers A, Johnston P, Woodcock M, Joiner M, Marples B. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int J Radiat Oncol Biol Phys. 2004;58:410-419.
75. Dealmodovar JM, Bush C, Peacock JH, Steel GG, Whitaker SJ, Mcmillan TJ. Dose-rate effect for DNA-damage induced by ionizing-radiation in human tumor-cells. Radiat Res. 1994;138(suppl):S93-S96.
76. Widel M, Przybyszewski WM. Inverse dose-rate effect for the induction of micronuclei in Lewis lung carcinoma after exposure to cobalt-60 gamma rays. Radiat Res. 1998;149:98-102.
77. 2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation. Radiat Res. 1999;151:659-669.
78. Macklis RM, Beresford BA, Palayoor S, Sweeney S, Humm JL. Cell-cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in lymphoma-cells. Int J Radiat Oncol Biol Phys. 1993;27:643-650.
79. Murtha AD. Review of low-dose-rate radiobiology for clinicians. Semin Radiat Oncol. 2000;10:133-138.
80. Winthrop MD, DeNardo SJ, Muenzer JT, Chi S-G, Gumerlock PH. p53-independent response of a human breast carcinoma xenograft to radio-immunotherapy. Cancer. 1997;80:2529-2537.
81. Kroger LA, DeNardo GL, Gumerlock PH, et al. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using Cu-67-2IT-BAT-Lym-1 radioimmunotherapy. Cancer Biother Radiopharm. 2001;16:213-225.
82. Ohnishi T, Takahashi A, Ohnishi K, Yonezawa M. Tumor suppressor p53 response is blunted by low-dose-rate radiation. Phys Med. 2001;17:215-216.
83. Amundson SA, Lee RA, Koch-Paiz CA, et al. Differential responses of stress genes to low dose-rate γ irradiation. Mol Cancer Res. 2003;1:445-452.
84. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Regulation of tumor-necrosis-factor gene-expression by ionizing-radiation in human myeloid-leukemia cells and peripheral-blood monocytes. J Clin Invest. 1991;87:1794-1797.
85. Ishii K, Hosoi Y, Yamada S, Ono T, Sakamoto K. Decreased incidence of thymic lymphoma in AKR mice as a result of chronic, fractionated low-dose total-body X irradiation. Radiat Res. 1996;146:582-585.
86. Hosoi Y, Miyachi H, Matsumoto Y, et al. Induction of interleukin-1 beta and interleukin-6 mRNA by low doses of ionizing radiation in macrophages. Int J Cancer. 2001;96:270-276.
87. Anderson RE, Williams WL, Tokuda S. Effect of low-dose irradiation upon T-cell subsets involved in the response of primed A/J mice to SaI cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1988;53:103-118.
88. Safwat A. The immunobiology of low-dose total-body irradiation: more questions than answers. Radiat Res. 2000;153:599-604.
89. Tilkin AF, Schaaflafontaine N, Vanacker A, Boccadoro M, Urbain J. Reduced tumor-growth after low-dose irradiation or immunization against blastic suppressor T-cells. Proc Natl Acad Sci USA. 1981;78:1809-1812.
90. North RJ. Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation: preferential elimination of suppressor T-cells allows sustained production of effector T-cells. J Exp Med. 1986;164:1652-1666.
91. Dunn PL, North RJ. Selective radiation-resistance of immunologically induced T-cells as the basis for irradiation-induced T-cell-mediated regression of immunogenic tumor. J Leukoc Biol. 1991;49:388-396.
92. Safwat A, Aggerholm N, Roitt I, Overgaard J, Hokland M. Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2. Eur J Cancer. 2004;40:1412-1417.
93. Hallahan D, Kuchibhotla J, Wyble C. Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. Cancer Res. 1996;56:5150-5155.
94. Hallahan DE, Kuchibhotla J, Wyble C. Sialyl Lewis X mimetics attenuate E-selectin-mediated adhesion of leukocytes to irradiated human endothelial cells. Radiat Res. 1997;147:41-47.
95. Friedman EJ. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des. 2002;8:1765-1780.
96. Miller GM, Kajioka EH, Andres ML, Gridley DS. Dose and timing of total-body irradiation mediate tumor progression and immunomodulation. Oncol Res. 2001;13:9-18.
97. Miller GM, Kim DW, Andres ML, Green LM, Cridley DS. Changes in the activation and reconstitution of lymphocytes resulting from total-body irradiation correlate with slowed tumor growth. Oncology. 2003;65:229-241.
98. Liu SZ. On radiation hormesis expressed in the immune system. Crit Rev Toxicol. 2003;33:431-441.
99. 3H β particles in normal human fibroblasts. Radiat Res. 2002;158:181-186.
100. Koziczak R, Gonciarz M, Krokosz A, Szweda-Lewandowska Z. The influence of split doses of gamma-radiation on human erythrocytes. J Radiat Res (Tokyo). 2003;44:217-222.
101. Zaichkina SI, Rozanova OM, Klokov DI, Aptikaeva GF, Akhmadieva AK, Smirnova EN. Low doses of radiation decrease the level of spontaneous and gamma-induced chromosomal mutagenesis in bone marrow cells of mice in vivo [in Russian]. Radiats Biol Radioecol. 2003;43:153-155.
102. Ikushima T, Aritomi H, Morisita J. Radioadaptive response: efficient repair of radiation-induced DNA damage in adapted cells. Mutat Res. 1996;358:193-198.
103. Takahashi A, Asakawa I, Yuki K, et al. Radiation-induced apoptosis in the scid mouse spleen after low dose-rate irradiation. Int J Radiat Biol. 2002;78:689-693.
104. Takahashi A, Kondo N, Inaba H, et al. Radiation-induced apoptosis in scid mice spleen after low dose irradiation. Adv Space Res. 2003;31:1569-1573.
105. Rigaud O, Moustacchi E. Radioadaptation for gene mutation and the possible molecular mechanisms of the adaptive response. Mutat Res. 1996;358:127-134.
106. Tskhovrebova LV, Makedonov GP, L'vova GN, Chekova VV, Maksimova TN, Zasukhina GD. The radioadaptive response in the lymphocytes of schizophrenia patients [in Russian]. Radiats Biol Radioecol. 1995;35:665-669.
107. Makedonov GP, Tskhovrebova LV, Semiachkina AN, Zasukhina GD. A defense mechanism of human cells in the radioadaptive response and antimutagenic activity of interferon has common paths [in Russian]. Genetika. 2000;36:393-398.
108. Feinendegen LE. Relative implications of protective responses versus damage induction at low dose and low-dose-rate exposures, using the microdose approach. Radiat Prot Dosimetry. 2003;104:337-346.
109. Feinendegen LE. Reactive oxygen species in cell responses to toxic agents. Hum Exp Toxicol. 2002;21:85-90.
110. Kipnis J, Avidan H, Markovich Y, et al. Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells. Eur J Neurosci. 2004;19:1191-1198.
111. Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4(+)CD25(+) regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA. 2002;99:15620-15625.
112. Kipnis J, Yoles E, Mizrahi T, Ben Nur A, Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol. 2002;130:78-85.